Evidence map›Paper›PMID 37602398›Full record

ArticleFuture oncology (London, England)2023

Rebecca Ibrahim, Khalil Saleh, Claude Chahine, Rita Khoury, Nadine Khalife, Axel Lecesne

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Future oncology (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. KRAS and EGFR inhibitors: a new step in the management of colorectal cancer.Translational gastroenterology and hepatology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rebecca IbrahimInternational Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
Khalil SalehInternational Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France.ORCID 0000-0002-2985-2202
Claude ChahineInternational Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
Rita KhouryInternational Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
Nadine KhalifeDepartment of Head & Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
Axel LecesneInternational Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
Institut Gustave Roussy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsRectal NeoplasmsHumansMutationProto-Oncogene Proteins p21(ras)KRAS protein, humanProto-Oncogene Proteins p21(ras)adagrasibcolorectal cancerKRASG12C mutationRASsotorasib

Identifiers

PMID37602398
OpenAlexW4386019470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.